Form 4: Director James D. Forbes Receives Dentsply Sirona RSU Grant

Dentsply Sirona Director James D. Forbes was granted 28,887 restricted stock units as part of his annual compensation.

Summary

• Director James D. Forbes acquired 28,887 restricted stock units (RSUs) of Dentsply Sirona (XRAY) common stock.
• The transaction occurred on June 3, 2026.
• The RSUs were granted at a price of $0, representing equity-based compensation.
• Following this transaction, Mr. Forbes holds a total of 38,887 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• The grant aligns the director's interests with those of shareholders through equity ownership.

Negatives

• None identified.

Risks

• The value of the equity grant is subject to market volatility and the future performance of Dentsply Sirona stock.

Future Outlook

The RSUs vest in full one year from the date of grant, on June 3, 2027.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure long-term alignment between leadership and shareholder interests in the dental technology sector.

Comparison to Industry Standards

• The use of RSUs as a primary component of director compensation is consistent with standard practices among S&P 500 and mid-cap healthcare companies.

Stakeholder Impact

• Shareholders benefit from the alignment of director incentives with company performance.

Next Steps

• Vesting of the 28,887 RSUs on June 3, 2027.

Key Dates

Keywords

Dentsply Sirona, XRAY, Form 4, Insider Trading, Restricted Stock Units, Director Compensation